Product Description
Bortezomib Injection IP is a medication used primarily in the treatment of multiple myeloma and mantle cell lymphoma, two types of cancer that affect the plasma cells in the bone marrow. It works by blocking the action of proteasomes, which are cellular structures responsible for breaking down proteins within cells. Bortezomib Injection IP is typically administered intravenously (into a vein) by a healthcare professional. By inhibiting proteasomes, bortezomib disrupts the normal processes that regulate cell growth and survival, leading to the death of cancer cells.
Other Details
Usage |
Commercial |
Brand |
Natco |
Storage |
Normal |
Packing |
Vail |
Form of Medicine |
Injection |
Packaging Type |
Box |
Dose/Strength |
2mg |
FAQs of Bortezomib Injection IP:
Q: What is Bortezomib Injection IP?
A: Bortezomib Injection IP is an injection used for the treatment of multiple myeloma and mantle cell lymphoma.
Q: What is the physical color and texture of Bortezomib Injection IP?
A: The physical color and texture of Bortezomib Injection IP are other than the usual texture.
Q: What is the shelf life of Bortezomib Injection IP?
A: The shelf life of Bortezomib Injection IP is up to 24 months.
Q: What are the storage instructions for Bortezomib Injection IP?
A: The storage instructions for Bortezomib Injection IP are cold and dry.
Q: What is the temperature needed for fermentation of Bortezomib Injection IP?
A: The temperature needed for fermentation of Bortezomib Injection IP is as per industry norms Celsius (oC).